| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,435.00
|
|
Change (%)
|
19.00 (1.34%)
|
|
Best Buy (RS)
|
1435.05(x24)
|
|
Best Sell (RS)
|
1435.8(x18)
|
|
Today's Range (RS)
|
1,426.85
-
1,443.60
|
|
52-Week Range (RS)
|
1,165.55
-
1,672.20
|
|
Beta (1 Year)
|
0.55
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50 |
| News |
|
Corporate Details |
| InvaGen receives EIR report for its facility in Hauppauge, New York |
| Cipla consolidated net profit declines 39.19% in the June 2026 quarter |
| Cipla drops after Q1 PAT tumbles 39% YoY to Rs 789 cr |
| Board of Cipla approves change in senior management |
| Cipla grants 24,709 stock options and ESARs |
| USFDA inspects Cipla subsidiary's manufacturing unit in New York |
| Volumes jump at Biocon Ltd counter |
| Cipla Ltd soars 2.53%, up for fifth straight session |
| Cipla to convene board meeting |
| Cipla receives revision in ESG rating |
|
|
|
| Incoporation Year : 1935 |
| Chairman : Y K Hamied |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Cipla Ltd
Cipla House Peninsula Buss Par,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013 |
Phone:91-22-24826000
Fax:91-22-24826120 |
| E-Mail : cosecretary@cipla.com, contactus@cipla.com |
| URL : http://www.cipla.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
12-Aug-2026 |
1461.55 |
-3.12 |
| 1Month |
20-Jul-2026 |
1441.45 |
-1.77 |
| 3Month |
19-May-2026 |
1409.80 |
0.44 |
| 6Month |
19-Feb-2026 |
1329.05 |
6.54 |
| 1Year |
19-Aug-2025 |
1548.90 |
-8.58 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Flexi Cap Fund |
2.65 |
2932.03 |
| Parag Parikh Flexi Cap Fund |
1.42 |
2114.28 |
| SBI Nifty 50 ETF |
0.74 |
1599.43 |
| ICICI Pru Value Fund |
1.34 |
817.53 |
| HDFC Focused Fund |
2.69 |
750.90 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,902.50 |
0.24 |
2,047.55 |
1,547.25 |
455,393.78 |
| Zydus Lifesciences Ltd |
1,109.00 |
0.36 |
1,205.65 |
835.85 |
110,224.17 |
| Lupin Ltd |
2,220.30 |
0.01 |
2,530.00 |
1,881.80 |
101,505.62 |
| Mankind Pharma Ltd |
2,402.30 |
0.47 |
2,670.00 |
1,909.90 |
98,747.34 |
| Dr Reddys Laboratories Ltd |
1,178.45 |
0.64 |
1,414.40 |
1,080.05 |
97,740.54 |
|
|
|
|